Doing Business in China: A JD Supra Legal Reader
For your convenience, here’s a roundup of recent legal commentary and analysis on a broad range of issues facing companies doing business in and with China: Life Sciences Health Industry China Briefing – June 2012 (Reed Smith): “China’s new patent regulations allowing the government to force drug companies to grant compulsory licenses for generic versions… Read more »
